Roger McClellan
Dr. ROGER O. McCLELLAN
DVM, MMS, DSc (Honorary), Dipl-ABT and ABVT;
Fellow-ATS, SRA, HPS, AAAR, IARA and AAAS; Member – National Academy of Medicine
Adviser: Inhalation Toxicology and Human Health Risk Analysis
News!
Follow the link below to view Dr. McClellan's talk at the 2022 Annual Meeting for the Society for Risk Analysis
Roger O. McClellan receives the 2022 Comparative Toxicology, Pathology and Veterinary Medicine Specialty Section Lifetime Achievement Award from the Society of Toxicology.
See the CTPVSS Member Highlights, Fall 2022.
Roger O. McClellan receives the Society for Risk Analysis 2021 Distinguished Achievement Award.
View Dr. McClellan's acceptance remarks from the SRA Annual Meeting.
BIOGRAPHY -- 2022
ROGER O. McCLELLAN, DVM, MMS, DSc (Honorary),
Dipl-ABT and ABVT;
Fellow-ATS, SRA, HPS, AAAR, IARA, ATS and AAAS
Member – National Academy of Medicine
Editor, Critical Reviews in Toxicology
Advisor: Inhalation Toxicology and Human Health Risk Analysis
ROGER O. McCLELLAN serves as an advisor to public and private organizations on issues of air quality in the ambient environment and work place using his expertise in inhalation toxicology, comparative medicine, aerosol science and human health risk analysis. He received his Doctor of Veterinary Medicine degree with Highest Honors from Washington State University in 1960 and a Master of Management Science degree from the University of New Mexico in 1980. He is a Diplomate of the American Board of Toxicology and the American Board of Veterinary Toxicology and a Fellow of the Academy of Toxicological Sciences.
He served as Chief Executive Officer and President of the Chemical Industry Institute of Toxicology (CIIT) in Research Triangle Park, NC from September 1988 through July 1999. During his tenure, the organization achieved international recognition for the development of scientific information under-girding important environmental and occupational health decisions and regulations. Prior to his appointment as President of CIIT, Dr. McClellan was Director of the Inhalation Toxicology Research Institute, and President and Chief Executive Officer of the Lovelace Biomedical and Environmental Research Institute, Albuquerque, New Mexico. The Institute continues operation today as a core element of the Lovelace Respiratory Research Institute. During his 22 years with the Lovelace organization, he provided leadership for development of one of the world's leading research programs concerned with the health effects of airborne radioactive and chemical materials. Prior to joining the Lovelace organization, he was a scientist with the Division of Biology and Medicine, U.S. Atomic Energy Commission, Washington, DC (1965-1966), and Hanford Laboratories, General Electric Company, Richland, WA (1957-1964). In these assignments, he conducted and managed research directed toward understanding the human health risks of internally deposited radionuclides.
Dr. McClellan is an internationally recognized authority in the fields of inhalation toxicology, aerosol science, comparative medicine, and human health risk analysis. He has authored or co-authored over 400 scientific papers and reports and edited 10 books. In addition, he frequently speaks on risk assessment and air pollution issues in the United States and abroad. He is active in the affairs of a number of professional organizations, including past service as President of the Society of Toxicology and the American Association for Aerosol Research. He serves in an editorial role for a number of journals, including service since 1987 as Editor of Critical Reviews in Toxicology. He serves or has served on the Adjunct Faculty of 8 universities.
Dr. McClellan has served in an advisory role to numerous public and private organizations. He has served on senior advisory committees for eight major federal agencies concerned with human health. This included service as Chairman of the Clean Air Scientific Advisory Committee, Environmental Health Committee, Research Strategies Advisory Committee, and Member of the Executive Committee, Science Advisory Board, U. S. Environmental Protection Agency; Member for 30 years, National Council on Radiation Protection and Measurements; Member, Advisory Council for Center for Risk Management, Resources for the Future; a former Member, Health Research Committee, Health Effects Institute; and service on National Academy of Sciences/National Research Council Committee on Toxicology (served as Chairman or 7 years), Risk Assessment for Hazardous Air Pollutants, Health Risks of Exposure to Radon, Research Priorities for Airborne Particulate Matter, as well as the Committee on Environmental Justice of the Institute of Medicine. He has served on the Board of Scientific Councilors for the Center for Environmental Health Research of the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry and on the National Institutes of Health Scientific Advisory Committee on Alternative Toxicological Methods. He served on the National Aeronautics and Space Administration Lunar Airborne Dust Toxicity Advisory Group.
Dr. McClellan's contributions have been recognized by receipt of a number of honors, including election in 1990 to membership in the National Academy of Medicine. He is a Fellow of the Society for Risk Analysis, the American Association for Aerosol Research, the Health Physics Society, the International Aerosol Research Assembly, and the American Association for the Advancement of Science and American Thoracic Society Fellow. In 1985, he received the American Conference of Governmental industrial hygienist Herbert Stokinger Award for pioneering research on the health effects of exposure to diesel engine exhaust. In 1997, he received the Thomas T. Mercer Prize for research on inhalable materials from the International Society for Aerosols in Medicine and the American Association for Aerosol Research. In 1998, he received the International Achievement Award of the International Society of Regulatory Toxicology and Pharmacology for outstanding contributions to improving the science used for decision making on chemical safety and the International Aerosol Fellow Award of the International Aerosol Research Assembly for outstanding contributions to aerosol science and technology. In 2002, he was inducted into the University of New Mexico Anderson School of Management Hall of Fame for contributions to the effective management of multi-disciplinary research organizations. He received the Society of Toxicology Arnold J. Lehman Award in 1992 for contributions to chemical safety, the Society’s Merit Award in 2003 for a distinguished career in toxicology, the Society’s Founders Award in 2009 for contributions to science-based safety/risk decision-making and the Society’s Distinguished Toxicology Scholar Award in 2018 for contributions to understanding the toxicity of inhaled radionuclides. In 2012, he received a career achievement award from the International Dose-Response Society and the American Association for Aerosol Research. and in 2014 from the Academy of Toxicological Sciences. In 2016, he received the American Veterinary Medical Association Meritorious Service Award for public service. In 2018, he was designated as an American Thoracic Society Fellow. In 2005, The Ohio State University awarded him an Honorary Doctor of Science degree for his contributions to comparative medicine and the science under-girding improved air quality. In 2006, he received the New Mexico Distinguished Public Service Award. In 2008, Washington State University presented Dr. McClellan the Regents Distinguished Alumnus Award, the highest recognition the University can bestow on an Alumnus.
Dr. McClellan has a long-standing interest in environmental and occupational health issues, especially those involving risk assessment and air quality and in the management of multidisciplinary research organizations. He is a strong advocate of science-based decision- making and the need to integrate data from epidemiological, controlled clinical, laboratory animal and cell studies to assess human health risks of exposure to toxic materials and to inform policy makers in developing standards and guidance to protect public health. He is internationally recognized for his knowledge of the health issues associated with a range of energy technologies, including nuclear power, coal combustion, oil/gas extraction and internal combustion engines, including the transition from traditional to clean diesel technology.